Rubicon Research Limited 
Dealstreet

AZB, Khaitan & Co act on Rubicon Research ₹1,377.5 crore IPO

Rubicon Research specializes in developing, manufacturing, and marketing branded specialty products for pharmaceutical companies.

Bar & Bench

Rubicon Research Limited has raised ₹1,377.5 from an initial public offerring comprising a fresh issue and an offer for sale by General Atlantic Singapore RR Pte. Ltd., the promoter selling shareholder.

AZB & Partners advised Rubicon Research on this IPO, according to the DRHP.

Khaitan & Co advised the Book Running Lead Managers i.e., Axis Capital Limited, IIFL Capital Services Limited, JM Financial Limited and SBI Capital Markets Limited, on this IPO.

The transaction team consisted of Subhayu Sen (Partner), Ayush Mohata (Partner), Aparna Bagree (Partner), Johann Valladares (Senior Associate), Associates Aayush Virani, Avantika Tanwar, Mehar Sharma.

Subhayu Sen, Aayush Mohata, Aparna Bagree

Rubicon Research is a pharmaceutical formulations company based in Mumbai that specializes in developing, manufacturing, and marketing branded specialty products for pharmaceutical companies.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

Also Read

Delhi High Court sends man to jail for a month for threatening court commissioner with gun

Delhi High Court orders retrospective enhancement of Law Researchers' remuneration

Bursting of firecrackers not protected under right to religion: Retired Justice Abhay Oka

Court complaint not necessary for police to lodge FIR under Section 195A IPC for threat to witness: Supreme Court

'Misuse of legal process': Supreme Court rejects appeal filed under NALSA scheme without convict's consent

SCROLL FOR NEXT